During this meeting, the advisory committee will: Review available safety and efficacy data for BPC-157, including preclinical studies and any available clinical evidence Consider public comments submitted by patients, practitioners, and industry stakeholders Evaluate the clinical need for compounded BPC-157 and the patient populations that would benefit Assess the compounding quality considerations specific to peptide formulations Issue a recommendation to the FDA on whether BPC-157 should be included on the 503A compounding list Possible outcomes include: Positive recommendation: PCAC advises the FDA to add BPC-157 to the 503A list, clearing the way for legal compounding nationwide
Great reminder, Gabriel
This article outlines an approach to interpreting and working up a high serum B12 in adults by separating four possibilities: intake-related elevation, disease-associated hypercobalaminemia (an elevated blood B12 associated with an underlying condition), analytical interference, and functional deficiency
Studies suggest that peptides purchased from online sources can have substantial impurities and contaminants
Recalls & Warnings May 14, 2016 Xylitol in Supplements Poses Danger for Dogs On May 12, 2016, the FDA warned consumers that xylitol, a popular sweetener found in chewable vitamins, chewing gum, breath mints, toothpaste and a variety of other products, is toxic to dogs
It also increases the body's ability to use fat for energy while slowing down the process that converts excess calories into fat
